Sanofi Confirmed as First Tenant of Translational Research Institute’s ENTRI Biomanufacturing Hub

Sanofi Joins TRI’s ENTRI Biomanufacturing Hub

Image: Grispb/stock.adobe.comGlobal healthcare company Sanofi will become the first tenant of the Translational Research Institute’s (TRI) new ENTRI biomanufacturing facility in Brisbane, marking a significant milestone for Queensland’s expanding biomedical sector. The tenancy comes as ENTRI nears completion and forms part of a broader expansion of the Translational Science Hub – a partnership linking Queensland researchers with Sanofi scientist…

Sanofi confirmed as first tenant of Translational Research Institute’s ENTRI biomanufacturing hub

Global healthcare company Sanofi will become the first tenant of the Translational Research Institute’s (TRI) new ENTRI biomanufacturing facility in Brisbane, the Institute announced, marking what it described as a significant milestone for Queensland’s biomedical sector. In a news release, TRI said Sanofi’s tenancy forms part of a broader expansion of the Translational Science Hub, which links local researchers with the company’s international …